The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
Open accessAbstract
This review on the role of neurofilaments as surrogate markers for axonal degeneration in neurological diseases provides a brief background to protein synthesis, assembly, function and degeneration. Methodological techniques for quantification are described and a protein nomenclature is proposed. The relevance for recognising anti-neurofilament autoantibodies is noted. Pathological implications are discussed in view of immunocytochemical, cell-culture and genetic findings. With reference to the present symposium on multiple sclerosis, the current literature on body fluid levels of neurofilaments in demyelinating disease is summarised.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NfL is a component of the axonal cytoskeleton and is primarily expressed in large-caliber myelinated axons11,12.”
From Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (2019) · cites this paper as [11]
Experimental — accuracy not yet measuredIn the citing paper
“Changes of NfL in bodily fluids have been linked to brain damage and brain atrophy in mouse models and multiple neurological disorders including proteopathic neurodegenerative diseases11,13–16.”
From Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (2019) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
The cell: a molecular approach
(1997) · Choice Reviews Online · doi:10.5860/choice.35-0264 · Cited by 1,465
Sternberger, L. A., & Sternberger, N. H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6126 · Cited by 1,158
A Structural Scaffolding of Intermediate Filaments in Health and Disease
Fuchs, E. V., & Cleveland, D. W. (1998) · Science · doi:10.1126/science.279.5350.514 · Cited by 1,013
Hoffman, P. N., & Lasek, R. J. (1975) · The Journal of Cell Biology · doi:10.1083/jcb.66.2.351 · Cited by 941
de Waegh, S. M., Lee, V. M. ‐., & Brady, S. T. (1992) · Cell · doi:10.1016/0092-8674(92)90183-d · Cited by 743
Neurofilament gene expression: a major determinant of axonal caliber.
Hoffman, P. N., Cleveland, D. W., Griffin, J. W., Landes, P. W., Cowan, N. J., & Price, D. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3472 · Cited by 719
A Mechanistic Analysis of Nondisruptive Axonal Injury: A Review
Maxwell, W. L., Povlishock, J. T., & Graham, D. I. (1997) · Journal of Neurotrauma · doi:10.1089/neu.1997.14.419 · Cited by 564
Tikka, T., & Koıstınaho, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7527 · Cited by 539
Anderton, B. H., Breinburg, D., Downes, M. J., Green, P. J., Tomlinson, B. E., ULRICH, J., Wood, J. N., & Kahn, J. (1982) · Nature · doi:10.1038/298084a0 · Cited by 534
Rosengren, L. E., Karlsson, J., Karlsson, J., Persson, L. I., & Wikkelsø, C. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67052013.x · Cited by 499
Neuronal Intermediate Filaments
Lee, M. K., & Cleveland, D. W. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.001155 · Cited by 446
Julien, J. (2001) · Cell · doi:10.1016/s0092-8674(01)00244-6 · Cited by 435
Mersiyanova, I., Perepelov, A. V., Polyakov, A. V., Sitnikov, V. F., Леонидовна, Д. Е., Oparin, R. B., Petrin, A. N., & Evgrafov, O. V. (2000) · The American Journal of Human Genetics · doi:10.1086/302962 · Cited by 421
Bomont, P., Cavalier, L., Blondeau, F., Hamida, C. B., Belal, S., Tazir, M., Demir, E., Topaloğlu, H., Korinthenberg, R., Tüysüz, B., et al. (2000) · Nature Genetics · doi:10.1038/81701 · Cited by 408
Neurofilaments are obligate heteropolymers in vivo
Lee, M. K., Xu, Z., Wong, P., & Cleveland, D. W. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.6.1337 · Cited by 381
Lee, M. K., Marszalek, J. R., & Cleveland, D. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90263-1 · Cited by 365
Hof, P. R., Morrison, J. H., & Cox, K. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.903010105 · Cited by 365 · cited 2×
“Others provided evidence that NfH SMI32 positive neurons are selectively lost in AD [89, 90, 91].”
BackgroundGeisler, N., Kaufmann, E., Fischer, S., Plessmann, U., & Weber, K. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01584.x · Cited by 359
Elevated neurofilament levels in neurological diseases
Norgren, N., Rosengren, L., & Stigbrand, T. I. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03219-0 · Cited by 351
Deregulation of Cdk5 in a Mouse Model of ALS
Nguyen, M. D., Larivière, R., & Julien, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00268-9 · Cited by 339
Aberrant neurofilament phosphorylation in Alzheimer disease.
Sternberger, N. H., Sternberger, L. A., & ULRICH, J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4274 · Cited by 338
Functions of intermediate filaments in neuronal development and disease
Larivière, R., & Julien, J. (2003) · Journal of Neurobiology · doi:10.1002/neu.10270 · Cited by 333
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
Malmeström, C., Haghighi, S., Rosengren, L., Andersen, O., & Lycke, J. (2003) · Neurology · doi:10.1212/01.wnl.0000098880.19793.b6 · Cited by 318
Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis
Lycke, J., Karlsson, J.-E., Andersen, O., & Rosengren, L. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.3.402 · Cited by 315
Geisler, N., & Weber, K. K. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90011-5 · Cited by 285
Nixon, R. A., Paskevich, P. A., Sihag, R. K., & Thayer, C. Y. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.4.1031 · Cited by 277
Intrinsic determinants of neuronal form and function
Letourneau, P. C. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90169-0 · Cited by 266
Roy, S., Coffee, P., Smith, G. M., Liem, R. K. H., Brady, S. T., & Black, M. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-18-06849.2000 · Cited by 245
SOD1 mutation is assosiated with accumulation of neurofilaments in amyotrophic lateral scelaries
Rouleau, G. A., Clark, A. W., Rooke, K., Pramatarova, A., Krizus, A., Suchowersky, O., Julien, J., & Figlewicz, D. A. (1996) · Annals of Neurology · doi:10.1002/ana.410390119 · Cited by 244
Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain
Pant, H. C. (1988) · Biochemical Journal · doi:10.1042/bj2560665 · Cited by 238
Williamson, T. L., Bruijn, L. I., Zhu, Q., Anderson, K. L., Anderson, S., Julien, J., & Cleveland, D. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9631 · Cited by 238
The Axon : structure, function, and pathophysiology
Waxman, S. G. (1995) · Oxford University Press eBooks · Cited by 236
Lew, J., Winkfein, R. J., Paudel, H. K., & Wang, J. H.-C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35696-5 · Cited by 232
Lees, J. F., Shneidman, P. S., Skuntz, S., Carden, M. J., & Lazzarini, R. A. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03032.x · Cited by 232
Muñoz, D. G., Greene, C., Perl, D. P., & Selkoe, D. J. (1988) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198801000-00002 · Cited by 225
Couillard‐Després, S., Zhu, Q., Wong, P. C., Price, D. L., Cleveland, D. W., & Julien, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9626 · Cited by 211
Neurofilament functions in health and disease
Julien, J. (1999) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)00004-5 · Cited by 209
Giant axonal neuropathy ? A unique case with segmental neurofilamentous masses
Asbury, A. K., Gale, M. K., Cox, S. C., Baringer, J. R., & Berg, B. O. (1972) · Acta Neuropathologica · doi:10.1007/bf00686905 · Cited by 209
Phosphorylation protects neurofilaments against proteolysis
Goldstein, M. E., Sternberger, N. H., & Sternberger, L. A. (1987) · Journal of Neuroimmunology · doi:10.1016/0165-5728(87)90049-x · Cited by 206
Shetty, K. T., Link, W. T., & Pant, H. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6844 · Cited by 206
Dong, D. L., Xu, Z. S., Chevrier, M. R., Cotter, R. J., Cleveland, D. W., & Hart, G. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85471-6 · Cited by 204
Liem, R. K. H., & Hutchison, S. B. (1982) · Biochemistry · doi:10.1021/bi00256a029 · Cited by 201
Phosphorylation of Neurofilaments Is Altered in Amyotrophic Lateral Sclerosis
Manetto, V., Sternberger, N. H., Perry, G. L., Sternberger, L. A., & Gambetti, P. (1988) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198811000-00007 · Cited by 197
Neurofilaments and neurological disease
Al‐Chalabi, A., & Miller, C. C. J. (2003) · BioEssays · doi:10.1002/bies.10251 · Cited by 189
Elder, G. A., Friedrich, V. L., Bosco, P., Kang, C., Gourov, A., Tu, P., Lee, V. M. ‐., & Lazzarini, R. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.3.727 · Cited by 180
Lee, J., Bruce‐Keller, A. J., Kruman, Y., Chan, S. L., & Mattson, M. P. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990701)57:1 · Cited by 179
Kinesin-mediated transport of neurofilament protein oligomers in growing axons
Yabe, J. T., Pimenta, A., & Shea, T. B. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.21.3799 · Cited by 174
Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy.
Fernyhough, P., Gallagher, A., Averill, S., Priestley, J. V., Hounsom, L., Patel, J. C., & Tomlinson, D. R. (1999) · Diabetes · doi:10.2337/diabetes.48.4.881 · Cited by 174
Gill, S. R., Wong, P. C., Monteiro, M. J., & Cleveland, D. W. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.5.2005 · Cited by 172
Glutamate Slows Axonal Transport of Neurofilaments in Transfected Neurons
Ackerley, S., Grierson, A. J., Brownlees, J., Thornhill, P., Anderton, B. H., Leigh, P. N., Shaw, C. E., & Miller, C. C. J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.1.165 · Cited by 170
Morrison, J. H., Lewis, D. A., Campbell, M. J., Huntley, G. W., Benson, D. L., & Bouras, C. (1987) · Brain Research · doi:10.1016/0006-8993(87)90914-0 · Cited by 164
Heins, S., Wong, P. C., Müller, S., Goldie, K. N., Cleveland, D. W., & Aebi, U. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.123.6.1517 · Cited by 162
Nixon, R. A. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00723.x · Cited by 161
Neurofilament protein synthesis and phosphorylation
Grant, P. G., & Pant, H. C. (2000) · Journal of Neurocytology · doi:10.1023/a:1010999509251 · Cited by 158
Phosphorylated Neurofilament Antigens in Neurofibrillary Tangles in Alzheimerʼs Disease
Cork, L. C., Sternberger, N. H., Sternberger, L. A., Casanova, M. F., Struble, R. G., & Price, D. L. (1986) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198601000-00005 · Cited by 158
A specific ELISA for measuring neurofilament heavy chain phosphoforms
Petzold, A., Keir, G., Green, A. J. E., Giovannoni, G., & Thompson, E. J. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00189-3 · Cited by 158
Self-citationRao, M. V., Houseweart, M. K., Williamson, T. L., Crawford, T. O., Folmer, J. S., & Cleveland, D. W. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.1.171 · Cited by 146
Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit
Silber, E., Semra, Y. K., Gregson, N. A., & Sharief, M. K. (2002) · Neurology · doi:10.1212/wnl.58.9.1372 · Cited by 143
Zhu, Q., Lindenbaum, M., Levavasseur, F., Jacomy, H., & Julien, J. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.1.183 · Cited by 142
Jacomy, H., Zhu, Q., Couillard‐Després, S., Beaulieu, J., & Julien, J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730972.x · Cited by 141
Tikka, T., Vartiainen, N. E., Goldsteins, G., Oja, S. S., Andersen, P. M., Marklund, S. L., & Koıstınaho, J. (2002) · Brain · doi:10.1093/brain/awf068 · Cited by 136
Roder, H. M., & Ingram, V. M. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03325.1991 · Cited by 133
Sternberger, L. A., Harwell, L. W., & Sternberger, N. H. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.4.1326 · Cited by 132
Semra, Y. K., Seidi, O., & Sharief, M. K. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00455-6 · Cited by 131
Eikelenboom, M. J., Petzold, A., Lazeron, R. H. C., Silber, E., Sharief, M. K., Thompson, E. J., Barkhof, F., Giovannoni, G., Polman, C. H., & Uitdehaag, B. M. J. (2003) · Neurology · doi:10.1212/01.wnl.0000041496.58127.e3 · Cited by 127
Self-citationGuidato, S., Tsai, L., Woodgett, J., & Miller, C. C. J. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66041698.x · Cited by 126
Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study
Petzold, A. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.043315 · Cited by 126
Self-citationSihag, R. K., & Nixon, R. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39718-2 · Cited by 125
An Immunoblot Study of Neurofilament Degradation In Situ and During Calcium‐Activated Proteolysis
Schlaepfer, W. W., Lee, C., LEE, V. M.-Y., & Zimmerman, U.-J. P. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb05442.x · Cited by 125
Sihag, R. K., & Nixon, R. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55143-7 · Cited by 121
Dong, D. L.-Y., Xu, Z.-S., Hart, G. W., & Cleveland, D. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20845 · Cited by 112
Effects of phosphorylation of the neurofilament L protein on filamentous structures.
Hisanaga, S., Gonda, Y., Inagaki, M., Ikai, A., & Hirokawa, N. (1990) · Cell Regulation · doi:10.1091/mbc.1.2.237 · Cited by 110
Sihag, R. K., & Nixon, R. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31280-2 · Cited by 109
Miyasaka, H., Okabe, S., Ishiguro, K., Uchida, T., & Hirokawa, N. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41583-9 · Cited by 109
Axonal transport of neurofilaments in normal and disease states
Miller, C. C. J., Ackerley, S., Brownlees, J., Grierson, A. J., Jacobsen, N. J. O., & Thornhill, P. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8425-7 · Cited by 95
A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family
Georgiou, D.-M., Zidar, J., Korošec, M., Middleton, L. T., Kyriakides, T., & Christodoulou, K. (2002) · Neurogenetics · doi:10.1007/s10048-002-0138-4 · Cited by 94
The basic aspects of therapeutics in amyotrophic lateral sclerosis
Strong, M. J. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00040-8 · Cited by 94
Zuchner, S. L., Vorgerd, M., Sindern, E., & Schröder, J. M. (2003) · Neuromuscular Disorders · doi:10.1016/j.nmd.2003.10.003 · Cited by 92
Chapter 38 Other inherited neuropathies
Boylan, K., & Chaudhry, V. (2006) · Handbook of clinical neurophysiology · doi:10.1016/s1567-4231(09)70099-1 · Cited by 88
Abnormal processing of multiple proteins in Alzheimer disease.
Zhang, H., Sternberger, N. H., Rubinstein, L. J., Herman, M. M., Binder, L. I., & Sternberger, L. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.20.8045 · Cited by 88
Phosphorylation of bovine neurofilament proteins by protein kinase FA (glycogen synthase kinase 3)
Guan, R., Khatra, B. S., & Cohlberg, J. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92971-6 · Cited by 85
Goldstein, M. E., Sternberger, L. A., & Sternberger, N. H. (1987) · Journal of Neuroimmunology · doi:10.1016/0165-5728(87)90048-8 · Cited by 84
Plaque biogenesis in brain aging and Alzheimer's disease
Su, J. H., Cummings, B. J., & Cotman, C. W. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00811-6 · Cited by 83
Age-Related Atrophy of Motor Axons in Mice Deficient in the Mid-Sized Neurofilament Subunit
Elder, G. A., Friedrich, V. L., Margita, A., & Lazzarini, R. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.1.181 · Cited by 82
Axonal degeneration and inflammation in acute optic neuritis
Petzold, A. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.017236 · Cited by 79
Self-citationWatson, D. F., Griffin, J. W., Fittro, K. P., & Hoffman, P. N. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09248.x · Cited by 77
Strong, M. J., Strong, W., Jaffe, H., Traggert, B., Sopper, M. M., & Pant, H. C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00094.x · Cited by 75
Alzheimer neurofibrillary tangles contain phosphorylated and hidden neurofilament epitopes.
Haugh, M. C., Probst, A., ULRICH, J., Kahn, J., & Anderton, B. H. (1986) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.11.1213 · Cited by 74
Nakamura, Y., Takeda, M., Angelides, K. J., Tanaka, T., Tada, K., & Nishimura, T. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90394-3 · Cited by 73
Axonal cytoskeletal pathology in aged and diabetic human sympathetic autonomic ganglia
Schmidt, R. E., Beaudet, L. N., Plurad, S. B., & Dorsey, D. A. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00806-8 · Cited by 73
Neurofilaments and motor neuron disease
Julien, J. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01049-0 · Cited by 71
Molecular architecture of the neurofilament
Hisanaga, S., & Hirokawa, N. (1990) · Journal of Molecular Biology · doi:10.1016/0022-2836(90)90080-6 · Cited by 68
Su, J. H., Cummings, B. J., & Cotman, C. W. (1998) · Acta Neuropathologica · doi:10.1007/s004010050920 · Cited by 67
Watson, D. F., Fittro, K. P., Hoffman, P. N., & Griffin, J. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)90691-n · Cited by 65
Moss, T., & Lewkowicz, S. J. (1983) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(83)90068-0 · Cited by 63
Lavedan, C. N., Buchholtz, S. A., Nussbaum, R. L., Albin, R. L., & Polymeropoulos, M. H. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02513-7 · Cited by 61
Betts, J. C., Blackstock, W. P., Ward, M. A., & Anderton, B. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.12922 · Cited by 60
Gou, J. P., Gotow, T., Janmey, P. A., & Leterrier, J. F. (1998) · Medical & Biological Engineering & Computing · doi:10.1007/bf02522486 · Cited by 60
Hisanaga, S., Matsuoka, Y., Nishizawa, K., Saito, T., Inagaki, M., & Hirokawa, N. (1994) · Molecular Biology of the Cell · doi:10.1091/mbc.5.2.161 · Cited by 59
Kashiwagi, K., Ou, B., Nakamura, S., Tanaka, Y., SUZUKI, M. T., & Tsukahara, S. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-0398 · Cited by 59
Classification of the hereditary motor and sensory neuropathies
Reilly, M. M. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200010000-00009 · Cited by 57
Axonal degeneration and disorders of the axonal cytoskeleton
Griffin, J. W., George, E. B., Hsieh, S., & Glass, J. D. (1995) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195082937.003.0020 · Cited by 55
Axonal Pathology in Subarachnoid and Intracerebral Hemorrhage
Petzold, A., Rejdak, K., Belli, A., Sen, J., Keir, G., Kitchen, N. D., Smith, M., & Thompson, E. J. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.407 · Cited by 51
Self-citationTreatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis
Petzold, A., Brassat, D., Mas, P., Rejdak, K., Keir, G., Giovannoni, G., Thompson, E. J., & Clanet, M. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1021sr · Cited by 48
Self-citationQuantification of neurodegeneration by measurement of brain-specific proteins
Petzold, A., Baker, D., Pryce, G., Keir, G., Thompson, E. J., & Giovannoni, G. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00092-4 · Cited by 47
Self-citationInfluence of neuronal location on antigenic properties of neurofibrillary tangles
Tabaton, M., Perry, G. L., AUTILIO‐GAMBETTI, L., Manetto, V., & Gambetti, P. L. (1988) · Annals of Neurology · doi:10.1002/ana.410230613 · Cited by 46
Temporal and spatial variations in slow axonal transport velocity along peripheral motoneuron axons
Xu, Z., & Tung, V. W.-Y. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00449-8 · Cited by 42
Cerebrospinal fluid markers in MS patients and their healthy siblings
Haghighi, S., Andersen, O., Odén, A., & Rosengren, L. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00197.x · Cited by 39
Belecky‐Adams, T. L., Wight, D. A., Kopchick, J., & Parysek, L. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-12-05056.1993 · Cited by 38
Chromatolytic neurons in Werdnig-Hoffmann disease contain phosphorylated neurofilaments
Lippa, C. F., & Smith, T. W. (1988) · Acta Neuropathologica · doi:10.1007/bf00688247 · Cited by 37
Swollen Cortical Neurons in Creutzfeldt-Jakob Disease Contain a Phosphorylated Neurofilament Epitope
Nakazato, Y., Hirato, J., Ishida, Y., HOSHI, S., Hasegawa, M., & FUKUDA, T. (1990) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199005000-00001 · Cited by 36
SPINAL CORD TRAUMA IN MAN: STUDIES OF PHOSPHORYLATED NEUROFILAMENT AND UBIQUITIN EXPRESSION
Martin, J. E., Mather, K., Swash, M., Garofalo, O., Dale, G. E., Leigh, P. N., & Anderton, B. H. (1990) · Brain · doi:10.1093/brain/113.5.1553 · Cited by 31
Hisanaga, S., Yasugawa, S., Yamakawa, T., Miyamoto, E., Ikebe, M., Uchiyama, M., & Kishimoto, T. (1993) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124107 · Cited by 29
Overexpression of neurofilament subunit M accelerates axonal transport of neurofilaments
Xu, Z., & Tung, V. W.-Y. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02390-8 · Cited by 29
Walker, A. K., Rymar, G., & Andrews, P. (2001) · Electrophoresis · doi:10.1002/1522-2683()22:5 · Cited by 29
Vartiainen, N., Tikka, T., Keinänen, R., Chan, P. H., & Koıstınaho, J. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00200-6 · Cited by 29
Hedreen, J. C., & Koliatsos, V. E. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199411000-00013 · Cited by 28
Neurofilament expression in human T lymphocytes.
Murphy, A., Breen, K. C., Long, A., Feighery, C., Casey, E. B., & Kelleher, D. P. (1993) · PubMed Central · Cited by 24
Axonal Charcot-Marie-Tooth Disease and the Neurofilament Light Gene (NF-L)
Lupski, J. R. (2000) · The American Journal of Human Genetics · doi:10.1086/302986 · Cited by 24
Age-related Atrophy of Motor Axons in Mice Deficient in the Mid-sized Neurofilament Subunit
Elder, G. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.999.181 · Cited by 24
Gottron, F. J., Turetskya, D., & Choi, D. W. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11698-v · Cited by 22
Phosphatase Resistance of ERK2 Brain Kinase PK40erk2
Roder, H., Hoffman, F., & Schröder, W. E. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052203.x · Cited by 22
Wang, S., Lees, G. J., Rosengren, L., Karlsson, J.-E., Hamberger, A., & Haglid, K. G. (1992) · Neurochemical Research · doi:10.1007/bf00966828 · Cited by 20
Nakazato, Y., Sasaki, A., Hirato, J., & Ishida, Y. (1987) · Biomedical Research · doi:10.2220/biomedres.8.369 · Cited by 20
Chance, P. F., & Reilly, M. M. (1994) · Current Opinion in Neurology · doi:10.1097/00019052-199410000-00002 · Cited by 19
Stubbs, E. B., Lawlor, M. W., Richards, M. P., Siddiqui, K., Fisher, M. A., Bhoopalam, N., & Siegel, G. J. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0615-8 · Cited by 18
Jaquet, P. E., Ferrer‐Alcón, M., Ventayol, P., Guimón, J., & Garcı́a-Sevilla, J. A. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01729-3 · Cited by 18
Human monoclonal antineurofilament antibody cross‐reacts with a neuronal surface protein
Sadiq, S. A., van den Berg, L. H., Thomas, F. P., Kilidireas, K., Hays, A. P., & Latov, N. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490290307 · Cited by 18
Herrmann, D. N., & Griffin, J. W. (2002) · Neurology · doi:10.1212/wnl.58.8.1141 · Cited by 17
Am, S., Nixon, N. B., Pt, D., & Dl, M. (1998) · PubMed · Cited by 16
Hashimoto, R., Nakamura, Y., Tsujio, I., Tanimukai, H., Kudo, T., & Takeda, M. (1999) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.1999.00610.x · Cited by 15
Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
Morimoto, T., Miyoshi, T., Fujikado, T., Tano, Y., & Fukuda, Y. (2003) · Investigative Ophthalmology & Visual Science · Cited by 2
Research works printed but not linked: 2
- Bö L, Grey matter pathology in early MS. In: Miller, DH, Filipi M, A.J. Thompson, editors. MAGNIMS Clinically Isolated Syndrome Workshop, The National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, 22.–23. Jan. MS NMR Research, Unit, Department of Neuroinflammation; 2004.
- Julien, 1999, Neurofilament functions in health and disease, Curr Opin Neurobiol, 9, 554, 10.1016/S0959-4388(99)00004-5 · DOI
Cited by
Sorted by citations
Neurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988
Self-citationDominantly Inherited Alzheimer Network, Preische, O., Schultz, S. A., Apel, A., Kuhle, J., Kaeser, S. A., Barro, C., Gräber, S., Kuder-Buletta, E., LaFougere, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0304-3 · Cited by 927
Vivo, D. C. D., Bertini, E., Swoboda, K. J., Hwu, W., Crawford, T. O., Finkel, R. S., Kirschner, J., Kuntz, N. L., Parsons, J. A., Ryan, M. M., et al. (2019) · Neuromuscular Disorders · doi:10.1016/j.nmd.2019.09.007 · Cited by 669
Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
Lu, C.-H., Macdonald-Wallis, C., Gray, E., Pearce, N., Petzold, A., Norgren, N., Giovannoni, G., Fratta, P., Sidle, K., Fish, M., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001642 · Cited by 563
Self-citationBlood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder
Hansson, O., Janelidze, S., Hall, S., Magdalinou, N., Lees, A. J., Andreasson, U., Norgren, N., Linder, J., Forsgren, L., Constantinescu, R., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003680 · Cited by 506
Metadata
- Authors
- Petzold, A.
- Affiliations
- UCL Queen Square Institute of Neurology (GB)
- Corresponding author
- Petzold, Axel
- ORCID
- Petzold, Axel
- Venue
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 233
- Issue
- 1-2
- Pages
- 183-198
- ISSN
- 0022-510X (ISSN-L)
- OpenAlex
- W2133652987
- Cited by
- 688
- References
- 135
- Citations by year
- 2026: 26 · 2025: 44 · 2024: 40 · 2023: 49 · 2022: 46 · 2021: 65 · 2020: 42 · 2019: 54 · 2018: 38 · 2017: 27 · 2016: 24 · 2015: 23 · 2014: 38 · 2013: 27 · 2012: 24
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- green
- discovery.ucl.ac.uk
- Locations
- Journal of the Neurological Sciences (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- neurofilaments, axonal injury, axonal degeneration, surrogate markers, neurofilament assembly, multiple sclerosis, demyelinating disease, neurodegeneration
- MeSH terms
- Animals, Axons, Enzyme-Linked Immunosorbent Assay, Glycosylation, Humans, Immunohistochemistry, Models, Biological, Nerve Degeneration, Phosphorylation, Blotting, Western, Biomarkers, Neurofilament Proteins, Protein Isoforms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review